Previous studies have shown that HNRNPA2B1 is overexpressed in breast cancer tissue, and that its encoded protein can activate the STAT3 and ERK1/2 signaling pathways, thereby promoting the tumorigenic potential of cancer cells. Here, HNRNPA2B1 is linked to breast cancer.